Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)

Not Applicable

Completed

• Conditions: Cancer; Smoking

• Registration Number: NCT03600038
• Lead Sponsor: Fred Hutchinson Cancer Center

Brief Summary

The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.

Detailed Description

Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.

Study Timeline

• Study Start: 2018-04-02
• Study First Submitted: 2018-07-17
• Study First Submitted QC: 2018-07-17
• Study First Posted: 2018-07-26
• Primary Completion: 2019-07-31
• Status Verified: 2019-12
• Study Completion: 2019-12-01
• Last Update Submitted: 2019-12-05
• Last Update Posted: 2019-12-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 59

Inclusion Criteria

• age 18 or older
• diagnosed with cancer in the past 12 months
• has smoked a cigarette (even a puff) in the past 30 days
• interested in learning skills to quit smoking
• willing to be randomly assigned to either smartphone application
• resides in US
• has at least daily access to their own smartphone
• knows how to login and download a smartphone application from the Apple app store or Android Play app store
• willing and able to read in English
• not currently using cessation medications or enrolled in other smoking cessation programs, and
• has never used the NCI's Quit Guide smartphone application.
• willing and able to complete one follow-up survey
• willing to provide email, phone, and mailing address.

Exclusion Criteria

• The exclusion criteria are opposite of the inclusion criteria listed above.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
30-day point prevalence abstinence	2 months post randomization	No smoking in the past 30 days, as reported 2 months post treatment.

Trial Locations

Locations (1)

Fred Hutchinson Cancer Research Center; 🇺🇸 Seattle, Washington, United States